MENU
SEP 15, 2020 Opens: 12:00 PM EDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Advancing Science: A Spatial Biology Conference

Spatial technologies are enabling new discoveries that advance our understanding of a range of biology, including viral host immune response and the tumor immune microenvironment. This virtual conference brings together research professionals, scientists, and clinicians from around the world to learn about and discuss recent discoveries in spatial biology.

 

Scientific tracks include:

  • COVID-19 Research.
  • Spatial Genomics Research.
  • Spatial Genomics Data Analysis.

Full agenda coming soon.

This free online event allows you to participate at the most convenient time for your location:

Europe: 9:00 AM-3:15 PM British Summer Time / 10:00 AM-4:15 PM Central European Time. September 15.

Americas: 11:00 AM-5:15 PM Eastern Time. September 15.

Asia Pacific: 11:00 AM- 5:15 PM Beijing Standard Time. September 16.


Speakers
  • Assistant Professor of Medicine, Beth Israel Deaconess Medical Center
  • Head of Department of Pathology, Medical University of Vienna (Medizinische Universität Wien)
  • Associate Professor; Director, WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine
  • Professor, Institute of Clinical Medicine, National Yang Ming University
  • Postdoctoral fellow at the Broad Institute of MIT and Harvard and Massachusetts General Hospital (MGH)
  • Investigator, Research Urology Assistant Professor of Research Surgery, Childrens Hospital Los Angeles, The Saban Research Institute
  • Assistant Professor of Medicine, Weill Medical College of Cornell University
  • Investigator, Research Urology Assistant Professor of Research Surgery, Childrens Hospital Los Angeles, The Saban Research Institute
  • Otto Krayer Professor of Systems Biology, Harvard Medical School
  • Associate Clinical Director for Innovation, MGH Cancer Center Assistant Professor of Medicine, Harvard Medical School
  • Assistant Professor, Beth Israel Deaconess Medical Center

Show Resources
N. America Agenda

Europe Agenda

APAC Agenda

Speakers

  • Z. Gordon Jiang, MD, PhD
    Assistant Professor of Medicine, Beth Israel Deaconess Medical Center
  • Renate Kain, MD, PhD
    Head of Department of Pathology, Medical University of Vienna (Medizinische Universität Wien)
  • Christopher E. Mason, PhD
    Associate Professor; Director, WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine
    Biography

      Dr. Christopher Mason is an Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction, as well as an affiliate of Memorial Sloan Kettering Cancer Center (MSKCC), Rockefeller University, Harvard Medical School, and Yale Law School. The Mason laboratory develops and deploys new biochemical and computational methods in functional genomics to elucidate the genetic basis of human disease and physiology. We create and deploy novel techniques in next-generation sequencing and algorithms for: tumor evolution, genome evolution, DNA and RNA modifications, and genome/epigenome engineering. We also work closely with NIST/FDA to build international standards for these methods (SEQC2, IMMSA, and Epigenomics QC groups), to ensure clinical-quality genome measurements and editing. We also work with NASA to build integrated molecular portraits of genomes, epigenomes, transcriptomes, and metagenomes for astronauts, which help establish the molecular foundations and genetic defenses for enabling long-term human spaceflight. He has won the NIH's Transformative R01 Award, the NASA Group Achievement Award, the Pershing Square Sohn Cancer Research Alliance Young Investigator award, the Hirschl-Weill-Caulier Career Scientist Award, the Vallee Scholar Award, the CDC Honor Award for Standardization of Clinical Testing, and the WorldQuant Foundation Scholar Award. He was named as one of the "Brilliant Ten" Scientists by Popular Science, featured as a TEDMED speaker, and called "The Genius of Genetics" by 92Y. He has >200 peer-reviewed papers and scholarly works that have been featured on the covers of Nature, Science, Cell, Nature Biotechnology, Nature Microbiology, and Neuron, as well as legal briefs cited by the U.S. District Court and U.S. Supreme Court. Coverage of his work has also appeared on the covers of the Wall Street Journal, New York Times, TIME, The LA Times, and across many media (ABC, NBC, CBS, Fox, CNN, PBS, NASA, NatGeo). He is an inventor on four patents, co-founded five biotechnology start-up companies, and serves as an advisor to many others.

    • Yang Muh-Hwa, MD, PhD
      Professor, Institute of Clinical Medicine, National Yang Ming University
    • Karin Pelka, PhD
      Postdoctoral fellow at the Broad Institute of MIT and Harvard and Massachusetts General Hospital (MGH)
      Biography

        Dr. Karin Pelka is a research fellow of the German Research Foundation and currently performing her postdoctoral training with Dr. Nir Hacohen at the Broad Institute of MIT and Harvard. By combining systems biology approaches with mechanistic studies, she aims to understand the general principles that shape the immunological states of human colorectal cancer. Karin was selected as member of the 2019 BroadIgnite cohort, a program supporting early career scientists working on high-risk, high-reward projects, is the recipient of the first Stand Up To Cancer Peggy Prescott Early Career Scientist Award in Colorectal Cancer Research and a Stand Up To Cancer Phillip A. Sharp Innovation in Collaboration Award. Karin was a scholar of the German National Academic Foundation and received her PhD in 2016 from the University of Bonn where she trained with Dr. Eicke Latz at the Institute of Innate Immunity.

      • Laura Perin, PhD
        Investigator, Research Urology Assistant Professor of Research Surgery, Childrens Hospital Los Angeles, The Saban Research Institute
      • Robert E. Schwartz, PhD
        Assistant Professor of Medicine, Weill Medical College of Cornell University
        Biography

          Dr. Robert Schwartz is an Assistant Professor of Medicine and of the Department of Physiology, and Biophysics, and Systems Biology at Weill Cornell Medicine. He completed his Ph.D. in Biomedical Engineering at the University of Minnesota. His thesis work was on the derivation of stem cell derived hepatocytes and in vitro liver model systems. He completed his insternship and residency in Internal Medicine at Washington University in St. Louis/Barnes Jewish Hospital. His fellowship in Gastroenterology and Hepatology with a focus on hepatology was completed at the Brigham and Women's Hospital. He did a postdoc at MIT and his research continued to focus on the development of stem cell derived hepatocytes as a model system to study human liver disease and for clinical therapy. In his own lab at Weill Cornell Medical College he has continued to focus his work on the clinical translation and research applications of stem cell derived hepatocytes and primary human hepatocytes. In recognition of his work, he was an University of Minnesota Doctoral Dissertation Fellow, an AGA Research Scholar, a UEG Rising Scholar, a Bohmfalk Clinical Scholar, and an Irma Hirsch Trust Scholar. He has >50 peer-reviewed papers and scholarly works that have been featured in Nature, Cell, Nature Chemical Biology, Cell Stem Cell, Journal for Clinical Investigation, and Gastroenterology. He is an inventor on three patents.

        • Sargis Sedrakyan, PhD
          Investigator, Research Urology Assistant Professor of Research Surgery, Childrens Hospital Los Angeles, The Saban Research Institute
        • Peter Sorger, PhD
          Otto Krayer Professor of Systems Biology, Harvard Medical School
        • David T. Ting, MD
          Associate Clinical Director for Innovation, MGH Cancer Center Assistant Professor of Medicine, Harvard Medical School
        • Ioannis Vlachos, PhD
          Assistant Professor, Beth Israel Deaconess Medical Center
        About us

         

         

         

         

        About NanoString Technologies, Inc.

        NanoString Technologies is a leading provider of life science tools for translational research. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 3,200 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company’s GeoMx™ Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections. For more information, please visit www.nanostring.com.

         

        Help

        General LabRoots Questions

        email support@labroots.com  

        Virtual Events and Webinars

        Supported Configurations

        • Operating System Internet Explorer Firefox Chrome Safari
          Vista IE8+ FF10+ Chrome15+
          Windows 7 IE8+ FF10+ Chrome15+
          Windows 8 IE10 FF10+ Chrome15+
          Mac OS X   FF10+ Chrome15+ Safari5.1+
        • Cookie settings: session cookies enabled
        • Browser configuration must have JavaScript enabled
        • Adobe Flash player 10.2 or later

        To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

        Internet Connection

        • A minimum of 100Kbps is recommended for audio-only events
        • A minimum of 300Kbps is recommended for speaker on-video events

        Computer Equipment

        • Screen Resolution: Minimum 1024x768
        • Video Card: 65,000 colors minimum
        • Sound card and speakers (or headphones) for hearing webcast in full format
        • Audio Card: 16-bit minimum
        • RAM: 512MB of free RAM

        Firewall Protocol

        • HTTP on port 80 or HTTPS on port 443
        • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
        • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

        Work-At-Home Attendees

        • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

        For A Seamless Experience

        When using a mobile device, FREE Mobile Apps are available:

        - For viewing Webinars:

        - For viewing Virtual Events

        Attendee Guide

        • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

        Virtual Event and Webinar Support:

        Continuing Education (CME/CE) Support

        Show Resources
        Event Countdown
        • 0 Days
        • 0 Hours
        • 0 Minutes
        • 0 Seconds
        Attendees
        • See more